Unicycive Therapeutics Inc (UNCY) Stock Analysis

Unicycive Therapeutics Inc (UNCY) is a publicly traded company in the HEALTHCARE sector. It trades at $7.23, carries a market capitalization of $197.05M. This page summarizes the public market data, fundamentals, and frequently asked questions for UNCY, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.23
• Market Cap: $197.05M
• EPS: $-2.25
• 52-Week High: $11.00
• 52-Week Low: $3.71

Market Sentiment

Unicycive Therapeutics Inc currently has a Neutral sentiment score of 0.06.

About Unicycive Therapeutics Inc

None

GNG Research Analysis

GNG Research scores Unicycive Therapeutics Inc (UNCY) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for UNCY.

Frequently Asked Questions

Does UNCY pay dividends?

Unicycive Therapeutics Inc (UNCY) does not currently pay a regular dividend.

What is UNCY's market cap?

Unicycive Therapeutics Inc (UNCY) has a market capitalization of $197.05M with a current stock price of $7.23.